DMARDs (biologic)

Response to: ‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’ by Humby et al
Maya H Buch, Andrew Melville, Dennis G McGonagle

Annals of the Rheumatic Diseases Jul 2019, annrheumdis-2019-215881; DOI: 10.1136/annrheumdis-2019-215881
Incidence and time trends of joint surgery in patients with psoriatic arthritis: a register-based time series and cohort study from Denmark
Jørgen Guldberg-Møller, Rene Lindholm Cordtz, Lars Erik Kristensen, Lene Dreyer

Annals of the Rheumatic Diseases Jul 2019, annrheumdis-2019-215313; DOI: 10.1136/annrheumdis-2019-215313
Presence of anti-rituximab antibodies predicts infusion-related reactions in patients with systemic lupus erythematosus
Chris Wincup, Madhvi Menon, Edward Smith, Ann Schwartz, David Isenberg, Elizabeth C Jury, Claudia Mauri

Annals of the Rheumatic Diseases Aug 2019, 78 (8) 1140-1142; DOI: 10.1136/annrheumdis-2019-215200
Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation?
Stefan Siebert, Neal L Millar, Iain B McInnes

Annals of the Rheumatic Diseases Aug 2019, 78 (8) 1015-1018; DOI: 10.1136/annrheumdis-2018-213654
Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study
Sophie Glatt, Peter C Taylor, Iain B McInnes, Georg Schett, Robert Landewé, Dominique Baeten, Lucian Ionescu, Foteini Strimenopoulou, Mark I L Watling, Stevan Shaw

Annals of the Rheumatic Diseases Aug 2019, 78 (8) 1033-1040; DOI: 10.1136/annrheumdis-2018-214943
Consensus-based recommendations for the management of juvenile localised scleroderma
Francesco Zulian, Roberta Culpo, Francesca Sperotto, Jordi Anton, Tadej Avcin, Eileen M Baildam, Christina Boros, Jeffrey Chaitow, Tamàs Constantin, Ozgur Kasapcopur, Sheila Knupp Feitosa de Oliveira, Clarissa A Pilkington, Ricardo Russo, Natasa Toplak, Annet van Royen, Claudia Saad Magalhães, Sebastiaan J Vastert, Nico M Wulffraat, Ivan Foeldvari

Annals of the Rheumatic Diseases Aug 2019, 78 (8) 1019-1024; DOI: 10.1136/annrheumdis-2018-214697
Achieving lupus low-disease activity and remission states under belimumab in refractory systemic lupus erythematosus: time and organ involvement matter
Nabiha Sbeih, Alexis Mathian, Marc Pineton de Chambrun, Raphael Lhote, Noël Zahr, Micheline Pha, Fleur Cohen-Aubart, Julien Haroche, Miguel Hié, Sophie Jouffroy, Neila Benameur, Hervé Devilliers, Zahir Amoura

Annals of the Rheumatic Diseases Jul 2019, annrheumdis-2019-215732; DOI: 10.1136/annrheumdis-2019-215732
Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al
Elise van Mulligen, Johanna M W Hazes, Angelique E A M Weel, Pascal H P de Jong

Annals of the Rheumatic Diseases May 2019, annrheumdis-2019-215641; DOI: 10.1136/annrheumdis-2019-215641
Comparisons of hepatitis C viral replication in patients with rheumatoid arthritis receiving tocilizumab, abatacept and tofacitinib therapy
Yi-Ming Chen, Wen-Nan Huang, Tsai-Ling Liao, Jun-Pen Chen, Sheng-Shun Yang, Hsin-Hua Chen, Tsu-Yi Hsieh, Wei-Ting Hung, Yi-Hsing Chen, Der-Yuan Chen

Annals of the Rheumatic Diseases Jun 2019, 78 (6) 849-850; DOI: 10.1136/annrheumdis-2018-214400
TARA study: a new perspective on tapering drugs in RA
Debashish Mishra, Arghya Chattopadhyay, Sanjay Jain, Varun Dhir

Annals of the Rheumatic Diseases May 2019, annrheumdis-2019-215594; DOI: 10.1136/annrheumdis-2019-215594

Main menu

DMARDs (biologic)

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

DMARDs (biologic)

Pages